Evidence map›Paper›PMID 36777093›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Development of digital voice biomarkers and associations with cognition, cerebrospinal biomarkers, and neural representation in early Alzheimer's disease.

Ihab Hajjar, Maureen Okafor, Jinho D Choi, Elliot Moore, Anees Abrol, Vince D Calhoun, Felicia C Goldstein

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Digital speech-based markers to advance prognosis in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  6. Mandarin speech-based early detection of SCD: a feature-fusion residual network method.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  7. Article
  8. Benchmarking speech biomarkers of Alzheimer's against cognitive and neural measures.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Detecting Alzheimer's disease using digital virtual reality cognitive tests.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ihab HajjarDepartment of Neurology University of Texas Southwestern Dallas Texas USA.
Maureen OkaforDepartment of Neurology Emory University School of Medicine Atlanta Georgia USA.
Jinho D ChoiDepartment of Computer Science Emory University Atlanta Georgia USA.
Elliot MooreSchool of Electrical & Computer Engineering Georgia Institute of Technology Atlanta Georgia USA.
Anees AbrolTri-institutional Center for Translational Research in Neuroimaging and Data Science Georgia State University Georgia Institute of Technology Emory University Atlanta Georgia USA.
Vince D CalhounTri-institutional Center for Translational Research in Neuroimaging and Data Science Georgia State University Georgia Institute of Technology Emory University Atlanta Georgia USA.
Felicia C GoldsteinDepartment of Neurology Emory University School of Medicine Atlanta Georgia USA.
Emory University · USCenter for Translational Research in Neuroimaging and Data Science · USGeorgia Institute of Technology · USGeorgia State University · US

Funding

The role of the renin-angiotensin-endothelial pathway in ADRF1AG051633 · NIA · EMORY UNIVERSITY · PI HAJJAR, IHAB M, QUYYUMI, ARSHED A · 2015 to 2017
$6.0M
A biomarker-driven trial of angiotensin receptor blockers for prodromal AlzheimerR01AG049752 · NIA · EMORY UNIVERSITY · PI GOLDSTEIN, FELICIA C. · 2016 to 2020
$3.8M
Digital Biomarkers for Alzheimer’s DiseaseR01AG070861 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI IHAB M HAJJAR · 2021 to 2026
$3.4M
Building a high-resolution multi-omic AD interactome with the AMP-AD and M2OVE-AD ProjectsRF1AG057470 · NIA · EMORY UNIVERSITY · PI HAJJAR, IHAB M, SEYFRIED, NICHOLAS THOMAS · 2017 to 2017
$3.1M
Hypertension, angiotensin receptor blockers, and cognition: effects and mechanismR01AG042127 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAJJAR, IHAB M · 2012 to 2017
$3.0M
Mid-Career Program for Vascular Contributions to Alzheimer's diseaseK24AG062786 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI HAJJAR, IHAB M · 2020 to 2024
$915k
Digital Biomarkers for Alzheimers DiseaseR56AG070861 · NIA · EMORY UNIVERSITY · PI HAJJAR, IHAB M · 2021 to 2021
$802k
NIA NIH HHS K24 AG062786NIA NIH HHS R01 AG042127NIA NIH HHS R01 AG049752NIA NIH HHS R01 AG070861NIA NIH HHS R56 AG070861NIA NIH HHS RF1 AG051633NIA NIH HHS RF1 AG057470
6 · The paper itself

Abstract

Introduction: Advances in natural language processing (NLP), speech recognition, and machine learning (ML) allow the exploration of linguistic and acoustic changes previously difficult to measure. We developed processes for deriving lexical-semantic and acoustic measures as Alzheimer's disease (AD) digital voice biomarkers. Methods: We collected connected speech, neuropsychological, neuroimaging, and cerebrospinal fluid (CSF) AD biomarker data from 92 cognitively unimpaired (40 Aβ+) and 114 impaired (63 Aβ+) participants. Acoustic and lexical-semantic features were derived from audio recordings using ML approaches. Results: Lexical-semantic (area under the curve [AUC] = 0.80) and acoustic (AUC = 0.77) scores demonstrated higher diagnostic performance for detecting MCI compared to Boston Naming Test (AUC = 0.66). Only lexical-semantic scores detected amyloid-β status ( Discussion: These preliminary findings suggest that derived digital biomarkers may identify cognitive impairment in preclinical and prodromal AD, and may predict disease progression. Highlights: This study derived lexical-semantic and acoustics features as Alzheimer's disease (AD) digital biomarkers.These features were derived from audio recordings using machine learning approaches.Voice biomarkers detected cognitive impairment and amyloid-β status in early stages of AD.Voice biomarkers may predict Alzheimer's disease progression.These markers significantly mapped to functional connectivity in AD-susceptible brain regions.

Indexed as

Alzheimer's diseasediagnosisdigital biomarkerslexical semanticmild cognitive impairmentspeech

Identifiers

PMID36777093
PMCPMC9899764
OpenAlexW4320005044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.